• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

运用捕获-再捕获法估计法国洛林地区多发性硬化症的患病率和发病率。

Estimating the prevalence and incidence of multiple sclerosis in the Lorraine region, France, by the capture-recapture method.

机构信息

Nancy University Hospital - Clinical Epidemiology and Evaluation, France.

出版信息

Mult Scler. 2012 Sep;18(9):1244-50. doi: 10.1177/1352458512437811. Epub 2012 Feb 21.

DOI:10.1177/1352458512437811
PMID:22354740
Abstract

OBJECTIVE

The objective of this study was to assess the prevalence and incidence of multiple sclerosis (MS) in the Lorraine region, in France.

METHODS

Data from three sources - Regional Health Insurance System, medical records departments and the Lorraine registry of MS - and a capture-recapture method with log-linear models were used to estimate the prevalence and incidence of MS.

RESULTS

We identified 7193 records of reported MS corresponding to 4299 unique suspected cases of MS existing on 31 December 2008, in Lorraine. On the basis of the 4001 validated cases, the observed crude prevalence of MS was 170.9 cases per 100,000 inhabitants (95% confidence interval [CI]: 165.7; 176.3), and the observed annual crude incidence of MS was 4.4 cases per 100,000 inhabitants (95% CI: 3.6; 5.4). With the capture-recapture method, the estimated prevalence of MS was 4405.7 (95% CI: 4261.5; 4629.7), so an estimated 405 cases were not identified by the three sources. The estimated prevalence was 188.2 cases per 100,000 inhabitants (95% CI: 182.7; 193.8), and the estimated annual incidence was 8.5 cases per 100,000 inhabitants (95% CI: 7.3; 9.7).

CONCLUSIONS

The capture-recapture method allowed us to estimate an additional 10.1% of unobserved prevalent cases and to anticipate 47.5% of unobserved incident cases.

摘要

目的

本研究旨在评估法国洛林地区多发性硬化症(MS)的患病率和发病率。

方法

我们使用了三种来源的数据——地区健康保险系统、医疗记录部门和洛林 MS 登记处,以及对数线性模型的捕获-再捕获方法,来估计 MS 的患病率和发病率。

结果

我们在洛林地区共发现了 7193 例报告的 MS 记录,对应于 2008 年 12 月 31 日存在的 4299 例独特的疑似 MS 病例。基于 4001 例确诊病例,MS 的观察粗患病率为 170.9 例/10 万居民(95%置信区间[CI]:165.7;176.3),观察到的 MS 年粗发病率为 4.4 例/10 万居民(95%CI:3.6;5.4)。通过捕获-再捕获方法,估计的 MS 患病率为 4405.7(95%CI:4261.5;4629.7),因此有 405 例病例未被三种来源识别。估计的患病率为 188.2 例/10 万居民(95%CI:182.7;193.8),估计的年发病率为 8.5 例/10 万居民(95%CI:7.3;9.7)。

结论

捕获-再捕获方法使我们能够估计另外 10.1%的未观察到的现患病例,并预测 47.5%的未观察到的发病病例。

相似文献

1
Estimating the prevalence and incidence of multiple sclerosis in the Lorraine region, France, by the capture-recapture method.运用捕获-再捕获法估计法国洛林地区多发性硬化症的患病率和发病率。
Mult Scler. 2012 Sep;18(9):1244-50. doi: 10.1177/1352458512437811. Epub 2012 Feb 21.
2
Estimating the prevalence of systemic sclerosis in the Lorraine region, France, by the capture-recapture method.采用捕获-再捕获法估计法国洛林地区系统性硬化症的患病率。
Semin Arthritis Rheum. 2013 Apr;42(5):530-8. doi: 10.1016/j.semarthrit.2012.10.001. Epub 2013 Jan 2.
3
Increasing incidence of multiple sclerosis among women in Lorraine, Eastern France.法国东部洛林地区女性多发性硬化症发病率上升。
Mult Scler. 2007 Sep;13(8):962-7. doi: 10.1177/1352458507077938. Epub 2007 Jul 10.
4
National estimate of multiple sclerosis incidence in France (2001-2007).法国多发性硬化症发病率的全国估计(2001-2007 年)。
Mult Scler. 2012 Aug;18(8):1108-15. doi: 10.1177/1352458511433305. Epub 2012 Feb 1.
5
Incidence and prevalence of multiple sclerosis in Saskatoon, Saskatchewan.萨斯喀彻温省萨斯卡通市多发性硬化症的发病率和患病率
Neurology. 2007 Sep 18;69(12):1224-9. doi: 10.1212/01.wnl.0000276991.13764.77.
6
Gender as a prognostic factor and its impact on the incidence of multiple sclerosis in Lorraine, France.性别作为一种预后因素及其对法国洛林地区多发性硬化症发病率的影响。
J Neurol Sci. 2009 Nov 15;286(1-2):14-7. doi: 10.1016/j.jns.2009.07.012. Epub 2009 Aug 18.
7
[Prevalence of multiple sclerosis in Colombia].[哥伦比亚多发性硬化症的患病率]
Rev Neurol. 2000;31(12):1101-3.
8
Possible increasing risk of multiple sclerosis in Catania, Sicily.西西里岛卡塔尼亚地区多发性硬化症风险可能增加。
Neurology. 2005 Oct 25;65(8):1259-63. doi: 10.1212/01.wnl.0000180628.38786.85.
9
Prevalence of multiple sclerosis in Buenos Aires, Argentina using the capture-recapture method.采用捕获-再捕获法对阿根廷布宜诺斯艾利斯多发性硬化症患病率的研究
Eur J Neurol. 2009 Feb;16(2):183-7. doi: 10.1111/j.1468-1331.2008.02375.x. Epub 2008 Dec 9.
10
The rising prevalence and changing age distribution of multiple sclerosis in Manitoba.曼尼托巴多发性硬化症的发病率上升和年龄分布变化。
Neurology. 2010 Feb 9;74(6):465-71. doi: 10.1212/WNL.0b013e3181cf6ec0. Epub 2010 Jan 13.

引用本文的文献

1
Risk of secondary progression in patients with highly active multiple sclerosis treated with natalizumab: a real-life study.利妥昔单抗治疗中高危多发性硬化症患者的继发进展风险:一项真实世界研究。
J Neurol. 2024 May;271(5):2216-2224. doi: 10.1007/s00415-024-12266-8. Epub 2024 Feb 29.
2
Prognostic impact of epileptic seizures in multiple sclerosis varies according to time of occurrence and etiology.癫痫发作对多发性硬化症的预后影响因发生时间和病因而异。
Eur J Neurol. 2022 Dec;29(12):3537-3546. doi: 10.1111/ene.15551. Epub 2022 Sep 25.
3
Age-period-cohort analysis of the incidence of multiple sclerosis over twenty years in Lorraine, France.
法国洛林地区二十年来多发性硬化症发病率的年龄-时期-队列分析。
Sci Rep. 2022 Jan 19;12(1):1001. doi: 10.1038/s41598-022-04836-5.
4
Multiple Sclerosis in the Campania Region (South Italy): Algorithm Validation and 2015-2017 Prevalence.坎帕尼亚地区(意大利南部)的多发性硬化症:算法验证和 2015-2017 年的患病率。
Int J Environ Res Public Health. 2020 May 13;17(10):3388. doi: 10.3390/ijerph17103388.
5
Use of healthcare services by patients with multiple sclerosis in France over 2010-2015: a nationwide population-based study using health administrative data.2010 - 2015年法国多发性硬化症患者的医疗服务使用情况:一项基于全国人口的使用卫生行政数据的研究。
Mult Scler J Exp Transl Clin. 2019 Dec 18;5(4):2055217319896090. doi: 10.1177/2055217319896090. eCollection 2019 Oct-Dec.
6
Prevalence of multiple sclerosis in an urban population of Sivas province in Turkey.土耳其锡瓦斯省城市人口多发性硬化症的患病率。
Turk J Med Sci. 2019 Feb 11;49(1):288-294. doi: 10.3906/sag-1808-112.
7
Five-year outcome in the copaxone observatory: a nationwide cohort of patients with multiple sclerosis starting treatment with glatiramer acetate in France.Copaxone 观察研究 5 年结果:法国使用醋酸格拉替雷治疗多发性硬化症的全国性队列研究。
J Neurol. 2019 Apr;266(4):888-901. doi: 10.1007/s00415-019-09211-5. Epub 2019 Feb 7.
8
High performance of cerebrospinal fluid immunoglobulin G analysis for diagnosis of multiple sclerosis.脑脊液免疫球蛋白 G 分析对多发性硬化症诊断的高性能。
J Neurol. 2019 Apr;266(4):902-909. doi: 10.1007/s00415-019-09212-4. Epub 2019 Feb 1.
9
The Importance of Sex Stratification in Autoimmune Disease Biomarker Research: A Systematic Review.《自身免疫性疾病生物标志物研究中性别分层的重要性:系统评价》。
Front Immunol. 2018 Jun 4;9:1208. doi: 10.3389/fimmu.2018.01208. eCollection 2018.
10
Generational changes in multiple sclerosis phenotype in North African immigrants in France: A population-based observational study.法国北非移民多发性硬化症表型的代际变化:一项基于人群的观察性研究。
PLoS One. 2018 Mar 27;13(3):e0194115. doi: 10.1371/journal.pone.0194115. eCollection 2018.